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Abstract: Background: The JAK/STAT (Janus Tyrosine Kinase, Signal
Transducers and Activators of Transcription) pathway is associated
with cytokine or growth factor receptors and it is critical for growth
control, developmental regulation and homeostasis. The use of porcine
ocular cells as putative xenotransplants appears theoretically possible.
The aim of this study was to investigate the response of various porcine
ocular cells in vitro to human cytokines in regard to the activation of
JAK-STAT signaling pathways.
Methods: Porcine lens epithelial cells, pigmented iris epithelial cells and
pigmented ciliary body cells were used in this study. These cells were
isolated from freshly enucleated porcine eyes by enzymatic digestion.
Cultured cells between passages 3–8 were used in all experiments.
Electromobility shift assay (EMSA), proliferation assay, immunoﬂuo-
rescence staining and ﬂow cytometry were used to evaluate the
JAK-STAT signaling pathway in these cells.
Results: JAK/STAT signaling pathways could be activated in porcine
pigmented epithelial ciliary body cells, in pigmented iris epithelial cells
and in lens epithelial cells in response to porcine and human interferons
and cytokines. All cells showed very strong STAT1 activation upon
stimulation with porcine interferon-gamma. Porcine ocular cells also
respond to human cytokines; IFN-alpha induced strong activation of
STAT1 in EMSA, ﬂow cytometry and immunoﬂuorescence experiments
whereas activation of STAT3 was less strong in EMSA, but strong in
ﬂow cytometry and immunoﬂuorescence. Human recombinant IL-6
activated STAT3 and human IL-4 activated STAT6. With the help of
immunoﬂuorescence assay and ﬂow cytometry we observed nuclear
localization of STAT proteins after activation of porcine ocular cells
with cytokines and interferons. Human IFN-a had an inhibitory eﬀect
on porcine ocular cells in proliferation assays.
Conclusion: Our study demonstrated that some types of human cyto-
kines and interferon activate intracellular JAK-STAT signaling path-
ways in porcine ocular cells. We hypothesize that direct stimulation of
the JAK-STAT pathway in porcine cells in response to human cytokines
will lead to complications or failure, if pig-to-human ocular tissue xeno-
transplantation were to be carried out. For successful xenotransplanta-
tion among other obstacles there must be new approaches developed to
regulate signaling pathways.
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Introduction
The pig has been used extensively in experimental
studies of human eye diseases and disorders [1–3],
as well as a possible source of xenotransplantation
[4–9]. For example, glaucoma and retinitis pigmen-
tosa models [1,10–12] and retinal conditions such
as proliferative vitreoretinopathy [13] and retinal
detachment [14] have been modeled on pigs. Por-
cine ocular cells share many morphological fea-
tures with the human eye [15–17]. Porcine eyes
have also similar size with human eyes. Because
there is limited availability of human organs and
cells in terms of clinical transplantation, pigs may
be an alternative source.
Age-related macular degeneration (AMD) is a
degenerative disease of the macula that can cause
irreversible loss of central vision. AMD is charac-
terized by macular changes consisting of retinal
pigment epithelium (RPE) abnormalities and dru-
sen [18]. Current investigations for developing
treatments for retinal atrophy have shown the
importance of RPE. Degeneration or dysfunction
of the RPE can lead to photoreceptor degeneration
and as a consequence to blindness. RPE cells are
of great interest to researchers working in the ﬁeld
of tissue engineering and cell transplantation
[19,20].
Studies in animal models demonstrated that the
transplantation of RPE cells can delay the course
of degenerative diseases. Although the ﬁrst
attempts to transplant RPE cells into the subreti-
nal space in humans suﬀering from AMD were less
successful, RPE cell transplantation is still
favoured as a future therapeutic option, and much
work has been carried out to develop cell trans-
plants [20]. In a recently published paper, Melville
et al. [21] discuss the possibilities of stem cell-
derived RPE transplantation into subretina space
of patients with dry AMD.
The highly pigmented outer layer of the ciliary
body continues into the RPE. Iris pigment epithe-
lium and RPE possess the same embryologic ori-
gin. Rezai et al. [22] have shown that iris pigment
epithelial cells were able to take over the functions
of RPE cells, serving as an autologous graft for
transplantation in a rat model. These results sug-
gest that pigmented iris or pigmented ciliary body
cells transplanted into the subretinal space might
substitute the RPE. We speculate that also porcine
iris or porcine pigmented ciliary body cells might
substitute the RPE in humans.
In the last decade, the major progress has been
made in the area of pig-to-human xenotransplanta-
tion. However, it is practically overlooked whether
major players of inﬂammation, human cytokines,
and interferons are able to activate signaling path-
ways in porcine ocular cells. Although the eye is
known as an immunologically privileged organ,
induction of cytokines in the ocular cells could be
an early trigger of the inﬂammatory response, as it
is known to occur after infection. Levels of inter-
feron-gamma (IFN-c), tumor necrosis factor-alpha
(TNF-a), IL-1, IL-2, IL-6 were shown to be ele-
vated in vitreous aspirates of patients with uveitis,
proliferative vitreoretinopathy, and other inﬂam-
matory eye diseases [23–25]. However, there are
only few studies researching the eﬀect of human
cytokines on pig tissues and vice versa [26]. Thus,
it has been shown that human IFN-c and interleu-
kin (IL)-1 beta do not have an eﬀect on the expres-
sion of RANTES in porcine endothelial cells [26].
Zhang et al. [27] reported that porcine IL-2
showed almost no eﬀects on human T cells and
practically did not promote porcine T-cell prolifer-
ation, although other research groups have shown
the eﬀects of human IL-2 on porcine cells [28,29].
Recently, Manna et al. [30] have demonstrated
that human dendritic cells (DC) activated by
human IL-15 were cytotoxic toward allogeneic and
xenogeneic endothelial cells via apoptotic reaction.
Cellular assays remain the critical tool to elucidate
the mechanism of xenogeneic rejection.
Signal transducers and activators of transcrip-
tion (STAT) proteins are a class of transcription
factors that become activated upon tyrosine phos-
phorylation. They are a family of cytoplasmic pro-
teins with roles as signal messengers and
transcription factors that participate in normal cel-
lular responses to cytokines and growth factors
[31–34]. To date, there are seven STAT family
members identiﬁed in mammals. Frequently, the
activity of certain STAT family members is associ-
ated with human malignancies, inﬂammatory
responses, and acute rejection reactions [35,36].
STAT1 has been described as upregulated during
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40], and there are also reports of roles of STAT4
and STAT6 during the allograft rejection [41] and
during T helper cell diﬀerentiation [42]. It has been
shown that neutralizing the transcription factor
STAT1 with a decoy oligodeoxynucleotide has a
powerful, long-lasting anti-inﬂammatory eﬀect
[43,44] and may be considered for treating acute,
and possibly, chronic graft rejections [45,46].
Targeting these STAT transcription factors is
considered as a useful approach to inﬂuence acute
rejection reactions and prolongate the life of organ
transplants.
This study was undertaken to delineate the
molecular basis of human interferon and cytokine
actions toward porcine ocular tissue.
Speciﬁcally, we examined whether STAT pro-
teins could be activated in porcine ocular cells in
response to human interferon and human cyto-
kines, and whether either of them are involved in
JAK–STAT signaling in these cells.
Materials and methods
Chemicals and reagents
Human recombinant IL-6 (hIL-6), human recom-
binant IL-4 (hIL-4), and porcine recombinant
interferon-gamma (pIFN-c) were from R&D Sys-
tems (Minneapolis, MN, USA). Roferon-A,
human recombinant interferon-alpha (hIFN-a),
was obtained from Hoﬀman-La Roche Ltd. (Rein-
ach, Switzerland). Polyclonal antibodies against
human STAT1, STAT2, STAT3, and STAT6 were
from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). Primary rabbit polyclonal antibodies
against phosphorylated human STAT proteins for
immunoﬂuorescence experiments were from Cell
Signaling (Danvers, MA, USA). Secondary anti-
bodies conjugated with Alexa Fluor 488 (goat anti-
mouse) and Alexa Fluor 555 (goat anti-rabbit)
were purchased from Invitrogen (Carlsbad, CA,
USA). Alexa Fluor 488 mouse anti-human phos-
pho-STAT1 (epitope Y701), anti-phospho-STAT3
(epitope Y705), anti-phospho-STAT6 (epitope
Y641), as well as isotype-matched IgG for ﬂow
cytometry experiments were purchased from BD
Biosciences (San Jose, CA, USA). All cell culture
reagents were obtained from Invitrogen. All cell
culture plasticware was purchased from TPP
(Trasadingen, Switzerland).
Cells
Porcine eyes from domestic pigs (4–6 months old,
both males and females) were enucleated directly
post mortem at the local abattoir. Ex vivo dissec-
tion of porcine lens epithelial cells (pLEC) were
performed by isolation of anterior lens capsules
with the adherent epithelium from freshly enucle-
ated porcine eyes. Only clear lenses were used. Pig-
mented porcine iris epithelial cells (pIEC) as well
as pigmented cells of ciliary bodies (pCBC) were
isolated by enzymatic digestion in a trypsin/EDTA
solution (0.05/0.02% w/v) for 15 min at 37 °Ca s
previously described [47] and seeded in 75-cm
2 cul-
ture ﬂasks in Dulbecco’s minimal essential medium
(DMEM), supplemented with 10% heat-inacti-
vated fetal calf serum (FCS), 2 mM L-glutamine,
and standard amounts of antibiotics. Cells were
maintained as subconﬂuent cultures by passaging
twice weekly. All experiments have been performed
in passages 3–8. The ARPE-19, Colo 205, Daudi,
and HepG2 cell lines were purchased from ATCC
(Manassas, VA, USA) and cultivated according to
the ATCC recommendations in 5% CO2/95% air
at 37 °C.
Proliferation assay
Cell proliferation was evaluated using cultures of
10 000 cells per well in 24-well plates in the absence
or presence of 500 U/ml of hIFN-a for the indi-
cated time period (on days 2, 4, and 5) as it was
previously described [48]. Cells were trypsinized,
and cell numbers were determined by live
cell counting using a hematocytometer and 0.4%
trypan blue reagent. Mean values and standard
deviations were calculated. The experiments were
carried out three times in triplicates for each cell
type.
Electromobility shift assay
To examine the eﬀects of cytokines on the activa-
tion of STAT proteins, electromobility shift assay
(EMSA) was performed as it was previously
described [49,50]. Brieﬂy, 1 day before the treat-
ment, subconﬂuent cells were starved overnight in
a serum-free medium. Cytokine treated and
untreated cells (negative control) were lysed in a
low-salt buﬀer (20 mM HEPES, pH 7.9, 10 mM
KCl, 1 mM EDTA; 1 mM ethylene glycol tetraace-
tic acid (EGTA), 0.2% NP-40, 10% glycerol,
0.1 mM Na3VO4,1 m M phenylmethanesulfonyl
ﬂuoride (PMSF), 1 mM dithiothreitol (DTT), 2 lg/
ml aprotinin, 1 lg/ml leupeptin, 1 lg/ml pepstatin)
at 4 °C for 10 min. After centrifugation for 1 min
at 12 0009 g, the supernatant (cytoplasmic
extract) was removed, and the pelleted nuclei were
incubated in a high-salt buﬀer (same as low-salt
buﬀer), but with 420 mM NaCl and 20% glycerol
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fugation at 12 0009 ga t4°C. The supernatant
was designated as the nuclear extract. The protein
concentration was determined using the Bio-Rad
Protein Assay (Bio-Rad Laboratories, Hercules,
CA, USA) according to the manufacturer’s
instructions. Bovine serum albumin was used as a
standard. All nuclear extracts were stored at –
80 °C. For the EMSA, nuclear extracts were incu-
bated for 20 min at room temperature in 20 mM
HEPES, pH 7.9, 4% Ficoll, 1 mM MgCl2,4 0m M
KCl, 0.1 mM EGTA, 0.5 mM DTT, 160 mg/ml
poly(dI-dC)xpoly(dI-dC) with 1 ng of
32P-labeled
oligonucleotides. Samples were separated on a 5%
non-denaturing polyacrylamide gel at 400 V for
4 h at 4 °C. The oligonucleotide probes corre-
sponding to STAT response element sequences are
summarized in Table 1. O15 probe binds to
STAT1–STAT2–p48 complex; bCas contains the
sequence of the b-casein promoter and binds to
STAT1, STAT5, and STAT6 homodimers; Ce
binds to STAT 6 homodimers and M67 probe
binds to STAT1, STAT1:3, STAT3, and STAT4
homo-/heterodimers. The experiments were carried
out ﬁve times.
Immunoﬂuorescence staining
Porcine ocular cells were cultured on cover glasses
in 24-well tissue culture dishes. Cells were left
untreated (negative control) or incubated with
appropriate cytokines for 20 min at 37 °C. Then,
cells were ﬁxed in a freshly prepared (50 : 50)
methanol/acetone mixture for 20 min on ice and
were further incubated with 10% goat serum in
PBS for 1 h at room temperature. Anti-phospho-
STAT antibodies were used as primary antibodies.
Goat anti-mouse Alexa Fluor 488 and goat anti-
rabbit Alexa Fluor 555 were used as secondary
antibodies, and the preparations were examined on
confocal laser scanning microscope (Zeiss LSM
510, Oberkochen, Germany). Microscopic images
were collected and analyzed using proprietary
image acquisition LSM software, version 3.2. The
experiments were carried out four times.
Analysis of activated STAT proteins by ﬂow cytometry
Porcine cells were incubated for 20 min with
appropriate cytokines or left untreated as a neg-
ative control. Cells were ﬁxed with 2% parafor-
maldehyde for 20 min and then permeabilized in
90% methanol for 30 min. All cells were stained
for 1 h with Alexa Fluor 488-conjugated anti-
phospho-STAT1, anti-phospho-STAT3, or anti-
phospho-STAT6 antibodies as it is indicated in
ﬁgure legends. Mean ﬂuorescence intensity of
stained cells was quantitatively analyzed using a
FACSCalibur ﬂow cytometer and the CellQuest
Pro Software (Becton Dickinson, Franklin
Lakes, NJ, USA). The experiments were carried
out four times.
Results
Interferon-alpha-induced growth inhibition
The eﬀect of hIFN-a on the proliferation of pCBC,
pLEC, and pIEC cells was analyzed by quantita-
tion of cell viability using a trypan blue staining.
Three independently performed experiments gave
the results presented in Fig. 1. The percentage of
dead cells in cultures with and without IFN-a did
not exceed 7%. As shown on Fig. 1, exogenously
added hIFN-a at a concentration of 500 U/ml sup-
pressed the proliferation of pCBC, pLEC, and
pIEC. In cultures without IFN-a the cell number
increased whereas in the presence of IFN-a cell
proliferation was inhibited between 19 and 37% on
day 2, 30–50% on day 4, and 35–65% on day 5.
pLEC were more sensitive to hIFN-a treatment
compared with pCBC and pIEC.
JAK–STAT activation in porcine ocular cells
Electromobility shift assay experiments
To determine whether interferons and cytokines
induce any known STAT protein in porcine eye,
the EMSA was carried out with nuclear extracts of
pCBC, pLEC, and pIEC and probed with four oli-
gonucleotides (O15, bCas, Ce, and M67) that rec-
ognize all known STAT proteins. Untreated cells
were used as negative controls, and for positive
controls, ARPE-19, Daudi, HepG2, and Colo 668
cell lines were treated with appropriate cytokines.
The cells were stimulated for 20 min with pIFN-c
or hIFN-a, or with hIL-6, or hIL-4. Five indepen-
dently performed experiments gave the results pre-
sented in Figs 2–5. Figure 2A shows that
stimulation with hIFN-a activates a STAT1–
STAT2–p48 complex that binds to the O15 probe.
All nuclear extracts of stimulated cells have been
veriﬁed by supershift experiments using speciﬁc
Table 1. Oligonucleotide sequences used for electromobility shift
assay experiments
Probe Sequence Reference
015 5′-CTAGGAAAGGGAAACCGAAACTGAAGC-3′ [48,49]
bCas 5′-ATCGATTTCTAGGAATTCAATCC-3′ [48,50]
Ce 5′-CACTTCCCAAGAACAGA-3′ [48,50]
M67 5′-GATCCATTTCCCGTAAATCAT-3′ [48,49]
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supershift experiment (Fig. 2B) demonstrated that
the O15 band disappears after incubation with
antibodies speciﬁc for STAT1 and STAT2,
whereas antibodies speciﬁc for STAT3 had no
eﬀect. IFN-a stimulated human retinal pigment
epithelial cell line ARPE-19 served as a positive
control (Fig. 2B).
When tested on M67 probe, a very strong activa-
tion of STAT1 proteins was observed after pIFN-c
stimulation (Fig. 3A). Untreated cells revealed no
STAT signals. hIFN-c-stimulated Colo 205 cell
line served as a positive control for STAT1 and the
HepG2 cell line stimulated with hIL-6 served as a
positive control for STAT3 (Fig. 3A,B). hIFN-a
induced STAT1, STAT1:STAT3, and STAT3 acti-
vation. After IFN-a stimulation, STAT3 proteins
were visible on all overexposed ﬁlms as a very
faint, but reproducible band. The STAT1:STAT3
heterodimers were visible as a band of intermediate
intensity. This STAT1:STAT3 band was migrating
between STAT1 and STAT3 bands (Fig. 3B).
Supershift experiment revealed that both STAT1
and STAT3 homodimers as well as STAT1:STAT3
heterodimers were supershifted after incubation
with anti-STAT1 and anti-STAT3 antibodies,
whereas STAT2-speciﬁc antisera had no eﬀect
(Fig. 3B). hIL-6 activated STAT3 in all tested cells
(Fig. 3A). These STAT3 bands could be supershif-
ted with antibodies speciﬁc for STAT3. hIL-6 stim-
ulated ARPE-19 cell line served as a positive
control for STAT3 supershift experiment
(Fig. 3C).
All nuclear extracts obtained from cells, stimu-
lated with hIL-4 and hIFN-a, were tested on bCas
probe. Strong STAT6 and STAT1 bands were
observed (Fig. 4A). The STAT6 band could be su-
pershifted with antibodies speciﬁc for STAT6
(Fig. 4B).
The STAT6 proteins were also visible when the
nuclear extracts were tested with the Ce probe
derived from the immunoglobulin heavy chain e
gene promoter. When the porcine cells were stimu-
lated with hIL-4, a strong band corresponding to
STAT6 was observed (Fig. 5).
Taken together, our gel shift data showed that
the intracellular STAT pathways are activated in
A
B
C
Fig. 1. Interferon-alpha induced inhibition of proliferation in
porcine ocular cells. Proliferation of porcine cells pCBC (A),
pLEC (B), pIEC (C) over a 5-day period in the absence (gray
bars) or presence (white bars) of 500 U/ml of human recombi-
nant IFN-a. Three independent sets of experiments have been
performed and are presented. Values are cell number
means  SD of n = 3 experiments. *statistically signiﬁcant dif-
ference by Student’s t-test (P < 0.02) between untreated and
treated cells.
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hIFN-a activating STAT1 and STAT3. Similarly,
hIl-4 activated STAT6, and hIL-6 activated
STAT3.
Flow cytometry analysis
To further conﬁrm the above observations, the
expression of phosphorylated STAT proteins was
measured by ﬂow cytometry after incubating por-
cine cells with hIFN-a, hIL-4, or hIL-6. Four inde-
pendently performed experiments gave the results
presented in Fig. 6. The samples were incubated
with anti-phospho-STAT1, STAT3, or STAT6
antibodies. Strong anti-phospho-STAT1 and anti-
phospho-STAT3 shifts were observed in response
to hIFN-a (Fig. 6, panels A and B, respectively).
Representative result of hIL-6-induced activation
of STAT3 is shown in Fig. 6 (panel C). The treat-
ment with hIL-4 induced a strong STAT6 shift as
shown in Fig. 6 (panel D).
Immunoﬂuorescence analysis
In the next set of experiments, we analyzed the
activation of STAT proteins by immunoﬂuores-
cence. Four independently performed experiments
gave the results presented in Fig. 7. The pLEC,
pIEC, and pCBC were cultured on cover glasses.
After stimulation with the appropriate cytokine
(or interferon), the cells were ﬁxed in methanol/
acetone mixture and probed with antibodies that
react only with phosphorylated STAT proteins.
These experiments conﬁrmed data gathered from
the EMSA and ﬂow cytometry. Representative
illustration out of four experiments of nuclear
expression of STAT1 is shown in Fig. 7. The
pLEC were left untreated (left panel) or were trea-
ted with hIFN-a (Fig. 7, right panel). Incubation
with hIFN-a caused the nuclear translocation of
STAT1 and STAT3, whereas the stimulation of
cells with IL-6 caused the translocation of STAT3
and IL-4 caused the translocation of STAT6 into
nuclei (data are not shown).
Discussion
The compatibility of cross-species activation and
costimulating molecules is a critical problem in the
xenogeneic context [51]. Severe shortage of alloge-
neic organ donors is the main reason for perform-
ing xenotransplantation of organs, and pigs are
considered as the most suitable species. However,
the compatibility between porcine organs and
humans needs to be studied on tissue, cellular and
molecular levels. The reports on the function of
human cytokines, for example, IL-2 on porcine
cells, are controversial [27–29], although a number
of cross-species interactions of porcine and human
integrins and selectins [52,53], activation of porcine
AB
Fig. 2. Electromobility shift assay analysis
of nuclear extracts from pCBC, pLEC,
and pIEC cells incubated with 32P-labeled
O15 probe. (A) Nuclear extracts were
prepared from unstimulated cells (negative
control) and from cells stimulated with
500 U/ml of human recombinant IFN-a
for 20 min. The position of the activated
STAT1–STAT2–p48 complex is indicated
by arrow. (B) Supershift experiment: IFN-
a-treated pCBC cells were incubated with
antisera speciﬁc for STAT1 (IFN-a +
aSTAT1), with antisera speciﬁc for
STAT2 (IFN-a + aSTAT2), or with
antisera speciﬁc for STAT3 (IFN-a +
aSTAT3). The nuclear extracts of human
retinal pigment epithelial cell line ARPE-
19, treated with 500 U/ml of IFN-a for
20 min were used as a positive control for
the O15 probe.
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interaction of porcine CD86 and human CD28
[55,56] and human CD2 with porcine CD28 are
conﬁrmed by diﬀerent investigators [55–57].
Type I interferons are central to innate and
adaptive immunity, and type I porcine interferons
are thoroughly characterized [58,59]. In the context
of cellular rejection of xenotransplant, IFN-c is
produced by the recipient (primate) eﬀector cells
[60]. However, little is known about the STAT
family in porcine ocular cells, although STAT4
and STAT6 recently have been cloned and
described [61]. We did not found in the literature
publications the study of the JAK–STAT pathway
in porcine cells in response to interferons and inter-
leukins. Also, as is mentioned above, just a few
studies were related to signal transduction in por-
cine cells in response to human cytokines and vice
versa are available. Thus, it is known that stimula-
tion of porcine vitreous-derived cells by human IL-
1a, IL-1b, and TNF can increase expression of
VEGF and IL-6 [62] and lead to procoagulant
changes in porcine endothelial cells [63].
To characterize the eﬀects of human cytokines
on porcine ocular cells, the JAK–STAT signaling
pathway was studied in detail. For stimulation of
porcine ocular cells pIFN-c, several human recom-
binant cytokines and hIFN-a were used in current
study.
The JAK–STAT pathway was originally
discovered through the study of interferon-induced
intracellular signal transduction [31,32,64]. Subse-
quently, the STAT proteins have been shown to be
induced by a wide variety of growth factors and
cytokines. The STAT proteins have diverse bio-
logic functions, which include roles in cell diﬀeren-
tiation, proliferation, development, apoptosis, and
inﬂammation [31,32,64,65]. The STAT proteins are
phosphorylated on tyrosine residues in response to
growth factors and cytokines. On phosphorylation,
STATs dimerize via SH2–phosphotyrosine interac-
tions and become competent to bind to DNA.
Phosphorylation causes the STATs to translocate
from the cytoplasm to the nucleus [31,64,65].
A
B
C
Fig. 3. Electromobility shift assay (EMSA) analysis of nuclear
extracts from pCBC, pLEC, and pIEC incubated with 32P-
labeled M67 probe. (A) Colo 205 cells were left untreated or
stimulated with 500 U/ml of human IFN-c for 20 min STAT1
positive control). HepG2 cells stimulated with 10 ng/ml of
human IL-6 were used as STAT3 positive control. pCBC,
pLEC, and pIEC cell extracts were either untreated or treated
with 10 ng/ml of porcine IFN-c, with 500 U/ml of human
IFN-a or with 10 ng/ml of human IL-6 for 20 min. The posi-
tion of activated STAT1 and STAT3 proteins is indicated by
arrows. (B) EMSA supershift experiment for STAT1 and
STAT3 upon stimulation with human IFN-a using M67 probe.
pCBC cells were left untreated or stimulated with human IFN-
a. IFN-a treated pCBC cells were incubated with antisera
speciﬁc for STAT1 (IFN-a + aSTAT1), with antisera speciﬁc
for STAT2 (IFN-a + aSTAT2) or with antisera speciﬁc for
STAT3 (IFN-a + aSTAT3). The nuclear extracts of human
Colo 205 cell line treated with 10 ng/ml of human IFN-c for
20 min were used as a positive control for the STAT1 and
HepG2 cells treated with 10 ng/ml of human IL-6 as a positive
control for STAT3. (C) EMSA supershift experiment for
STAT3 upon stimulation with IL-6 on M67 probe. pLEC cells
were left untreated or stimulated with human IL-6. IL-6-stimu-
lated pLEC cells were incubated with antisera speciﬁc for
STAT3 (Il-6 + aSTAT3). ARPE-19 cells were used as a positive
STAT3 control. The cells were treated the same way as porcine
cells: the cells left untreated or were stimulated with human
IL-6 for 20 min. ll-6-treated ARPE-19 were incubated with
antisera speciﬁc for STAT3 (Il-6 + aSTAT3).
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Porcine eye cells in response to human cytokineBecause of their diverse biologic functions, aberra-
tions in STAT signaling are predicted to have a
wide variety of consequences [35,65].
Interferon-alpha activates the JAK–STAT path-
way and exhibits immunomodulatory, antiviral
and anti-proliferative activity [31–35]. IFN- a is a
large family of proteins, which subdivided into 13
diﬀerent subtypes. There IFNs share high sequence
similarity. Currently, IFN-a is used in the treat-
ment for certain forms of cancer [34,35,49]. In cur-
rent study, we have examined STAT1, STAT3,
and STAT6 activation. Our data show that the
JAK–STAT pathway could be activated in all por-
cine eye cells.
Proliferation assay revealed that hIFN-a sub-
stantially suppresses the proliferation of all tested
porcine cells (Fig. 1). In all wells without hIFN-a
treatment cell number increased, in contrast hIFN-
a-treated pCBC, pLEC, and pIEC cells have
shown reduced proliferation (Fig. 1). The anti-pro-
liferative eﬀect of hIFN-a was described for many
human cells [34,48]. In this study, we demonstrate
that porcine ocular cells are sensitive to hIFN-a
treatment.
Using all four labeled oligoprobes (M67, O15,
bCas. and Ce), which allow for the detection of all
known activated STAT proteins in EMSA, we
were able to demonstrate that porcine eye cells are
able to activate diﬀerent STAT protein molecules
in response to human cytokines. EMSA data have
shown that porcine cells activate STAT1 in
response to porcine IFN-c, which is species spe-
ciﬁc. In addition, activation of STAT proteins was
induced by human cytokines (IL-4, IL-6) and
hIFN-a. Thus, STAT proteins activated by inter-
ferons, and human cytokines have also been veri-
ﬁed using STAT protein-speciﬁc antibodies in the
supershift experiments. As result of cellular activa-
tion, phosphorylated STATs were translocated to
the nuclei. This was conﬁrmed by confocal ﬂuores-
cence assay and ﬂow cytometry using phospho-
speciﬁc STAT antibodies.
In this study, we showed that the direct biologic
activities of human IFN-a and cytokines toward
porcine eye cells are mediated through the JAK–
STAT pathway. We hypothesize that activation of
JAK–STAT pathway by human cytokines may
modulate interaction of porcine cells with cells
of human immune system. Thus, activation of
STAT1 and STAT3 may lead to activation
of many genes involved in immunosuppression and
Fig. 5. Electromobility shift assay analysis of nuclear extracts
from pCBC, pLEC, and pIEC using the
32P-labeled Ce probe.
Human retina pigment epithelial cells ARPE-19 stimulated
with 10 ng/ml of IL-4 for 20 min were used as a positive con-
trol for the Ce probe. Porcine cells were left untreated (negative
control) or treated with IL-4. The position of activated STAT6
is indicated by arrow.
A
B
Fig. 4. Electromobility shift assay (EMSA) analysis of nuclear
extracts from pCBC, pLEC, and pIEC incubated with the
32P-
labeled bCas probe. (A) Nuclear extracts were prepared from
unstimulated porcine cells (negative control) and from cells
stimulated with 500 U/ml of human IFN-a or with 10 ng/ml
of human recombinant IL-4 for 20 min. Nuclear extracts from
Daudi cells treated with 500 U/ml of human IFN-a were used
as a positive control and compared with porcine cells. The
position of the activated STAT1, STAT5, and STAT6 proteins
is indicated by arrows. (B) EMSA supershift experiment for
STAT6 upon stimulation with IL-4 on bCas probe. pCBC cells
were left untreated or stimulated with human IL-4. IL-4-stimu-
lated pCBC cells were incubated with antisera speciﬁc for
STAT6 (IL-4 + aSTAT6). ARPE-19 cells were used as a posi-
tive STAT6 control. The cells were treated the same way as
porcine cells: left untreated or were stimulated with human IL-
4 for 20 min. lL-4-treated ARPE-19 were incubated with anti-
sera speciﬁc for STAT6 (Il-4 + aSTAT6).
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Fasler-Kan et al.induction of tolerance [66–68], and rebuilding the
balance of STAT1 and STAT3 signaling may be
explored as a useful approach to entertain survival
of xenogeneic transplants. These results provide
the ﬁrst demonstration that porcine ocular cells
can receive and transduce human interferon and
cytokine signals by the JAK–STAT signaling path-
way. Identiﬁcation of the activated STAT mole-
cules in other ocular cells and the target genes they
regulate would provide important insights into the
role of this family of transcription factors in the
eye and in ocular diseases. The JAK–STAT path-
way is not the only pathway, which could be acti-
vated in porcine ocular tissue in response to
human cytokines; therefore, other signaling path-
ways must be investigated in detail.
Xenotransplantation approach provides the
hope for a supply of organs and cells for patients
awaiting transplantation. Also, in the ﬁeld of oph-
thalmology, cell replacement is a promising
approach. It has a potential in retinal degenerative
diseases (retinitis pigmentosa and AMD), for
which no pharmacological and surgical treatments
are currently available [69]. In this study, we have
demonstrated that several STAT proteins could be
activated in porcine ocular cells in response to
human cytokines, and we speculate that xenotrans-
plantation would fail due to activation of unde-
sired intracellular signaling pathways. Prior
performing xenotransplantation, researches must
develop strategies to overcome these problems and
consequently prevent xenograft rejection.
AB
CD
Fig. 6. Flow cytometric analysis of phospho-STAT translocation in pCBC cells. Unstimulated cells (gray histograms) are compared
with cells stimulated for 20 min with diﬀerent cytokines (white histograms). (A) Stimulation with human IFN-a and analysis of
phospho-STAT1. (B) Stimulation with IFN-a and analysis of phospho-STAT3. (C) Stimulation with human Il-6 and analysis of
phospho-STAT3. (D) Stimulation with human IL-4 and analysis of phospho-STAT6.
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